PGT for Aneuploidy: Debating Universal vs. Discretionary Use

This video is for members-only until May 6, 2021 when it will be made public. If you are an ASRM member, please LOGIN now to view the video.
The field of Assisted Reproductive Technology continues to advance by improving methods to optimize outcomes for infertility patients. The “holy grail” is the ability to identify an embryo identified by testing to maximize its ability to implant. Preimplantation Genetic Testing for aneuploidy (PGT-A) has been touted as a major step toward the holy grail by some vs. an unnecessary up-charge by others. This webinar will be an engaging spirted debate of these opposing views.

Richard Paulson, MD
Eric Forman, MD

Mark Trolice, MD

Quick Links

Learn More About ASRM

Thousands of doctors, nurses, and other professionals in the field of reproductive medicine are advancing their careers with the latest news, continuing education, discounts, and networking opportunities. 

Ready to Join?  |  Renew